
Measured Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: coaching-forward metabolic care with compounded or brand-name GLP-1s
Measured scores below our bar on medical oversight — read the score breakdown before signing up.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care. Compounded semaglutide and tirzepatide (from $79/mo microdose) plus brand-name Wegovy and Zepbound, with a separate $49/mo membership.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Measured
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
Editorial score · methodology
Measured at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $79/mo (Weekly lower-dose semaglutide or tirzepatide (compounded).)
- What's included
- Medication · Consult · Coaching
- FDA status
- 1 FDA warning letter on record — see below
How we scored Measured
Each dimension is scored algorithmically from Measured’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $79/mo, Measured runs about 53% below the $169 median for GLP-1 providers.
Effectiveness25%
8.0/10Measured offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
4.9/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above) (last checked 2026-08-02).
Accessibility10%
5.7/10Measured's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
7.4/10Coaching/dietitian access included.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Measured review
Last checked August 2026- Confirmed current pricing across 5 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Measured
We walked Measured’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a short quiz about your goals and medical history.
- 2Provide a more detailed medical assessment / health history.
- 3A provider reviews your information and creates a personalized plan.
- 4Receive your prescription and medication by free home delivery.
- Membership priced from $49/mo shown up front; medication $149-$449/mo depending on option (Wegovy Pill, Zepbound, Wegovy, or microdose).
- Site notes you may be asked to complete lab work but does not state it as mandatory.
- Membership is a subscription that can be canceled at any time; no refund policy stated.
- Fast, free home delivery.
- Offers brand-name GLP-1s (Wegovy, Zepbound) alongside a microdose option.
Measured customer support
GLP-1 medications Measured offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Weekly lower-dose semaglutide or tirzepatide (compounded).
Compounded semaglutide.
Compounded tirzepatide.
Wegovy; cash-pay estimate, varies with coverage.
Zepbound; cash-pay estimate, varies with coverage.
Ready to get started?
Plans and promotions change often — check Measured's current pricing and active discounts before you decide.
What we like
- Membership includes 1:1 nutrition support and board-certified provider care
- Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
- Insurance or cash-pay options for brand-name medications
- Oral option available (Wegovy pill); cancel-anytime membership
Watch-outs
- Membership ($49/mo) is billed separately on top of medication cost
- Compounded medications are not FDA-approved
- Compounding/dispensing pharmacies not individually named
- State availability not published
Is Measured worth it? Our verdict
Measured positions itself around one thing: coaching-forward metabolic care with compounded or brand-name GLP-1s. It runs $79/month — toward the affordable end of the market. Coaching and follow-up are part of the package, not an upsell.
What gives Measured its own flavor: Nutrition coaching and Membership.
How much Measured actually costs
- Compounded semaglutide — $79/month
- Compounded semaglutide — $119/month
- Compounded tirzepatide — $229/month
- Brand-name semaglutide — $299/month
- Brand-name tirzepatide — $349/month
That puts Measured below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Sesame Care runs semaglutide and tirzepatide from $59/month — worth pricing against Measured before you commit.
Medications: what Measured prescribes
Measured prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Both routes are on the table: FDA-approved brand pens, or the cheaper compounded version that keeps the monthly cost down but isn't FDA-approved as a finished product.
Who Measured is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- want coaching and follow-up included, not sold separately.
Look elsewhere if you…
- need to bill insurance — like most of this market, it's cash-pay.
- want a provider with a clean regulatory record — note the FDA warning flagged at the top of this page.
Trust, safety, and medical oversight
It does have an FDA warning letter on file, which we flag at the top of this review — read it before starting. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Measured earns its place mainly on price: at $79/month it's one of the more affordable ways to stay on a GLP-1. One important caveat: it has an FDA warning letter on file — read it (flagged at the top of this review) and talk with a clinician before choosing it.
The Bottom Line
Measured scores below our bar on medical oversight — read the score breakdown before signing up.
Ready to start with Measured?
Starting at $79/month. See current pricing and start your free consultation.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Measured received an FDA warning letter dated February 20, 2026
The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Measured review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Measured's current pricing
Plans start at $79/month. Start your free consultation to check eligibility and today's price.